These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 372846)

  • 21. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease--a double-blind, placebo-controlled trial.
    Bode C; Schäfer C; Fukui H; Bode JC
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1367-73. PubMed ID: 9394106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease.
    Pár A; Horváth T; Beró T; Kádas I; Pakodi F; Jávor T
    Acta Physiol Hung; 1984; 64(3-4):449-54. PubMed ID: 6152369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The treatment of acute viral hepatitis with (+)-cyanidanol-3].
    Pelloni S; Berthet P; Blum AL; Doelle W; Goebell H; Kortüm K; Peter P; Poulsen H; Strohmeyer G; Tygstrup N
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1859-61. PubMed ID: 337476
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatoprotective agents in alcoholic liver disease.
    Morgan MY
    Acta Med Scand Suppl; 1985; 703():225-33. PubMed ID: 3937442
    [No Abstract]   [Full Text] [Related]  

  • 25. BSF compartmental analysis in healthy subjects and in patients with alcoholic liver disease.
    Biagi P; Brettoni A; Peccetti A
    Panminerva Med; 1982; 24(3):203-6. PubMed ID: 7177685
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of catergen treatment on the histochemical studies of post-alcohol lesions of the liver in rat].
    Ciszewska-Popiołek B; Romanowska-Sarlej J; Rzeszowska G; Patorska-Mach E
    Patol Pol; 1982; 33(1-2):71-84. PubMed ID: 6127662
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of (+)-cyanidanol-3.
    Lancet; 1982 Mar; 1(8274):737. PubMed ID: 6122024
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of acute viral hepatitis with (+)-cyanidanol-3.
    Blum AL; Berthet P; Doelle W; Goebell H; Kortüm K; Pelloni S; Peter P; Poulsen H; Strohmeyer G; Tygstrup N
    Lancet; 1977 Dec; 2(8049):1153-5. PubMed ID: 73062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The development of cianidanol and 3-palmitoyl-(+)-catechin as drugs for the treatment of liver diseases.
    Perrissoud D
    Prog Clin Biol Res; 1986; 213():559-69. PubMed ID: 3520595
    [No Abstract]   [Full Text] [Related]  

  • 30. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
    Fehér J; Deák G; Müzes G; Láng I; Niederland V; Nékám K; Kárteszi M
    Orv Hetil; 1989 Dec; 130(51):2723-7. PubMed ID: 2574842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Discriminatory analysis applied to bromsulphalein (BSF) kinetics: its use in the differential diagnosis of post-alcoholic chronic hepatopathies].
    Biagi P
    Quad Sclavo Diagn; 1980 Jun; 16(2):206-13. PubMed ID: 7244095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tolerance of nitrefazole in alcoholics with liver disease. A 4-week placebo-controlled double-blind study].
    Feuerlein W; Heesch D; Schmidt L; Werner HP; Bethge H; Görtelmeyer R
    Fortschr Med; 1984 Apr; 102(14):409-13. PubMed ID: 6144620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A study of the effects of procyanidol oligomers on capillary resistance in hypertension and in certain nephropathies (author's transl)].
    Lagrue G; Olivier-Martin F; Grillot A
    Sem Hop; 1981 Sep 18-25; 57(33-36):1399-401. PubMed ID: 6270799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatic tolerance of trithioparamethoxyphenylpropene in cirrhosis].
    Hecht Y
    Med Chir Dig; 1979; 8(2):175-8. PubMed ID: 379468
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of Endotelon in postoperative edema. Results of a double-blind study versus placebo in 32 female patients].
    Baruch J
    Ann Chir Plast Esthet; 1984; 29(4):393-5. PubMed ID: 6084452
    [No Abstract]   [Full Text] [Related]  

  • 36. [Propylthiouracil in therapy of alcohol-induced liver damage?].
    Schäfer SG
    Fortschr Med; 1991 Aug; 109(24):484-6. PubMed ID: 1937332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The free bilirubin tolerance test as a liver function test and its comparison with the BSF tolerance test].
    Gentilini P; Surrenti C; Candidi Tommasi A; Camilloni R
    Sperimentale; 1969; 119(4):281-97. PubMed ID: 5402934
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of alcoholic liver disease.
    Lucey MR
    Clin Liver Dis; 2009 May; 13(2):267-75. PubMed ID: 19442918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is (+)-Cyanidole-3 an effective therapeutic agent in liver diseases?].
    Blum AL
    Dtsch Med Wochenschr; 1978 May; 103(21):877. PubMed ID: 648373
    [No Abstract]   [Full Text] [Related]  

  • 40. [Controlled study of the effect of silymarin on alcoholic liver disease].
    Bunout D; Hirsch S; Petermann M; de la Maza MP; Silva G; Kelly M; Ugarte G; Iturriaga H
    Rev Med Chil; 1992 Dec; 120(12):1370-5. PubMed ID: 1343377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.